GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totalling 21,400 shares, an increase of 193.2% from the April 30th total of 7,300 shares. Based on an average daily trading volume, of 57,300 shares, the short-interest ratio is currently […]
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market Atlanta, GA, May 17, 2024 - GeoVax Labs, Inc. , a clinical-stage.
May 17, 2024 - GeoVax Labs, Inc. , a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a.
Biomea Fusion (NASDAQ:BMEA – Get Free Report) and GeoVax Labs (NASDAQ:GOVX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Earnings & Valuation This table compares Biomea […]
Biomea Fusion (NASDAQ:BMEA – Get Free Report) and GeoVax Labs (NASDAQ:GOVX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Analyst Recommendations This is a summary of […]